According to Protalix BioTherapeutics 's latest financial reports the company's current earnings (TTM) are -S$17.15 M. In 2023 the company made an earning of S$15.31 M an increase over its 2022 earnings that were of -S$15.46 M.The earnings displayed on this page is the company's Pretax Income.